Abstract
In this in vitro study, a series of amino-pyrazole derivatives were designed, synthesized, and evaluated against five human cancer cell lines (PC3, A549, HL60, HCT116, and SW620) for their anti-proliferative effects and inhibition of p53-MDM2 binding. The results of the biological evaluation showed that this series of compounds has improved inhibition of p53-MDM2 binding and anti-proliferative activities compared to previously designed pyrazole derivatives. Compound 6e exhibited the best potency for MDM2 inhibition (FP-IC50 = 9.83 μM). Compound 8e demonstrated a comprehensive potency (FP-IC50 = 15.34 μM) and anti-proliferative activity in all five of the cell lines tested (IC50 = 12.20-32.19 μM).
Keywords: Amino-pyrazole derivatives, synthesis, anti-cancer, p53-MDM2..
Letters in Drug Design & Discovery
Title:Synthesis and Cytotoxicity of Amino-Pyrazole Derivatives with Preliminary SAR
Volume: 14 Issue: 2
Author(s): Chunqi Hu, Jianfeng Shen and Wenting Du
Affiliation:
Keywords: Amino-pyrazole derivatives, synthesis, anti-cancer, p53-MDM2..
Abstract: In this in vitro study, a series of amino-pyrazole derivatives were designed, synthesized, and evaluated against five human cancer cell lines (PC3, A549, HL60, HCT116, and SW620) for their anti-proliferative effects and inhibition of p53-MDM2 binding. The results of the biological evaluation showed that this series of compounds has improved inhibition of p53-MDM2 binding and anti-proliferative activities compared to previously designed pyrazole derivatives. Compound 6e exhibited the best potency for MDM2 inhibition (FP-IC50 = 9.83 μM). Compound 8e demonstrated a comprehensive potency (FP-IC50 = 15.34 μM) and anti-proliferative activity in all five of the cell lines tested (IC50 = 12.20-32.19 μM).
Export Options
About this article
Cite this article as:
Hu Chunqi, Shen Jianfeng and Du Wenting, Synthesis and Cytotoxicity of Amino-Pyrazole Derivatives with Preliminary SAR, Letters in Drug Design & Discovery 2017; 14 (2) . https://dx.doi.org/10.2174/1570180813666160930162522
DOI https://dx.doi.org/10.2174/1570180813666160930162522 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Super aggregated form of Amphotericin B: a novel way to increase its therapeutic index
Current Pharmaceutical Design Electrochemical MIP-Sensors for Drugs
Current Medicinal Chemistry Central Sensitisation Phenomena in Primary Headaches: Overview of a Preventive Therapeutic Approach
CNS & Neurological Disorders - Drug Targets Synthesis, Characterization, and Inducing Tumor Cell Apoptosis of Two Ru(II) Complexes Containing Guanidinium as Ligands
Anti-Cancer Agents in Medicinal Chemistry Predicting the types of metabolic pathway of compounds using molecular fragments and sequential minimal optimization
Combinatorial Chemistry & High Throughput Screening Preparation, Characterization, and In Vitro Release of Vinorelbine Tartrate (VLBT)- Loaded Folate-conjugated Recombination Human Serum Albumin (rHSA) Nanoparticles with Different Degree of Cross-linking
Current Nanoscience Aptamer-based Homogeneous Analysis for Food Control
Current Analytical Chemistry Emerging Technologies, Recent Developments, and Novel Applications for Drug Metabolite Identification
Current Drug Metabolism Electrochemical Sensors for Hydroperoxides Based on Prussian Blue
Current Analytical Chemistry Novel Agents in Anticancer Drug Therapy I (Antiangiogenic Agents, Egfr Inhibitors)
Medicinal Chemistry Reviews - Online (Discontinued) Immune Cell-derived Vesicles: Modulators and Mediators of Inflammation
Current Pharmaceutical Design Antiviral Strategies Against Human Coronaviruses
Infectious Disorders - Drug Targets Absorption, Pharmacokinetics and Disposition of Biodegradable Nanoscale Preparations
Current Drug Metabolism Quantitative Proteomics Reveals Changes in Transporter Protein Abundance in Liver, Kidney and Brain of Mice by Pregnancy
Drug Metabolism Letters Stability Indicating Spectrofluorimetric Analysis of Metopimazine by Signal Enhanced - Partial Least Squares Chemometric Models: A Comparative Study
Current Pharmaceutical Analysis A Fluorescent g-C3N4 Nanosensor for Detection of Dichromate Ions
Current Analytical Chemistry Clinical and Forensic Signs Related to Cocaine Abuse
Current Drug Abuse Reviews Hydrophilic Interaction Liquid Chromatography-Tandem Mass Spectrometry for Drug Development
Current Drug Discovery Technologies Ganoderma lucidum: A Potential for Biotechnological Production of Anti-Cancer and Immunomodulatory Drugs
Recent Patents on Anti-Cancer Drug Discovery Ionic Liquid Mediated Tandem Synthesis of Bioactive Quinoline Based Thiophene/ Thiazole Linked Multi-Heterocomponent Ugi Adducts
Current Organic Chemistry